Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Weight loss injections could be key to controlling a chronic condition in thousands of Brits, new research suggests ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

India's weight-loss game is getting serious! The country's anti-obesity market is now worth ₹628 crore, and it's climbing ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...

Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...

A WOMAN has revealed that she has shed 7kg without the help of Mounjaro. Since becoming available on the NHS earlier this ...